PlainRecalls
CPSC Moderate Active

Geri-Care Pharmaceuticals Recalls Over-the-Counter Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning

Reported: January 26, 2022 Initiated: January 26, 2022 #22060

Product Description

This recall involves bottles of Geri-Care Brand over-the-counter acetaminophen and aspirin. The acetaminophen is 500mg with 1,000 tablets in the bottle. The aspirin was sold in 81mg with 300 and 1,000 tablets in the bottle and 325mg with 250 and 1,000 tablets in the bottle. Product Count Extra Strength Acetaminophen 500mg Tablets 1,000 Regular Strength Enteric Coated Aspirin 325mg Tablets 250 Regular Strength Enteric Coated Aspirin 325mg Tablets 1,000 Adult Low Dose Enteric Coated Aspirin 81mg Tablets 300 Adult Low Dose Enteric Coated Aspirin 81mg Tablets 1,000

Reason for Recall

The over-the-counter drug products contain regulated substances which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

Remedy

Consumers should immediately store the recalled products in a safe location out of sight and reach of children, and safely dispose of the recalled product as soon as is practicable. Contact Geri-Care Pharmaceuticals for a full refund or replacement over-the-counter drug product.

Frequently Asked Questions

What product was recalled?
This recall involves bottles of Geri-Care Brand over-the-counter acetaminophen and aspirin. The acetaminophen is 500mg with 1,000 tablets in the bottle. The aspirin was sold in 81mg with 300 and 1,000 tablets in the bottle and 325mg with 250 and 1,000 tablets in the bottle. Product Count Extra Strength Acetaminophen 500mg Tablets 1,000 Regular Strength Enteric Coated Aspirin 325mg Tablets 250 Regular Strength Enteric Coated Aspirin 325mg Tablets 1,000 Adult Low Dose Enteric Coated Aspirin 81mg Tablets 300 Adult Low Dose Enteric Coated Aspirin 81mg Tablets 1,000. Recalled by Geri-Care Pharmaceuticals, of Brooklyn, New York. Units affected: About 800.
Why was this product recalled?
The over-the-counter drug products contain regulated substances which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
What should consumers do?
Consumers should immediately store the recalled products in a safe location out of sight and reach of children, and safely dispose of the recalled product as soon as is practicable. Contact Geri-Care Pharmaceuticals for a full refund or replacement over-the-counter drug product.
Which agency issued this recall?
This recall was issued by the CPSC on January 26, 2022. Severity: Moderate. Recall number: 22060.